Company news for February 20, 2014

Zacks

•    La-Z-Boy Inc.’s (NYSE:LZB) shares dropped 2.3% after announcing fiscal third quarter earnings per share of $0.32, missing the Zacks Consensus Estimate of $0.35

•    Shares of Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) soared 24.4% to $6.16 after it received conditional approval from U.S. Food and Drug Administration for its new drug for treating symptomatic neurogenic orthostatic hypotension

•    Nabors Industries Ltd.’s (NYSE:NBR) shares jumped 13% after reporting fourth quarter earnings per share of $0.26, exceeding the Zacks Consensus Estimate of $0.20

•    Shares of CF Industries Holdings, Inc. (NYSE:CF) improved 5.1% to $237.62 after reporting fourth quarter adjusted earnings per share of $4.47, beating the Zacks Consensus Estimate by a cent  

 

Read the analyst report on LZB

Read the analyst report on CHTP

Read the analyst report on NBR

Read the analyst report on CF


Zacks Investment Research

Rates

View Comments (0)